Anzeige
Mehr »
Montag, 01.09.2025 - Börsentäglich über 12.000 News
Wie SuperBuzz am Freitag parabolisch durchstartete - und warum das erst der Anfang sein könnte
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A2PUP8 | ISIN: US2825591033 | Ticker-Symbol:
NASDAQ
29.08.25 | 21:59
9,020 US-Dollar
-4,25 % -0,400
1-Jahres-Chart
89BIO INC Chart 1 Jahr
5-Tage-Chart
89BIO INC 5-Tage-Chart

Aktuelle News zur 89BIO Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
08.08.89bio, Inc. - 10-Q, Quarterly Report1
07.08.89bio, Inc. - 8-K, Current Report1
04.08.89bio, Inc.: 89bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)134SAN FRANCISCO, Aug. 04, 2025 (GLOBE NEWSWIRE) -- 89bio, Inc. (the "Company" or "89bio") (Nasdaq: ETNB), a clinical-stage biopharmaceutical company focused on the development and commercialization...
► Artikel lesen
09.07.89bio, Inc.: 89bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)219SAN FRANCISCO, July 09, 2025 (GLOBE NEWSWIRE) -- 89bio, Inc. (the "Company" or "89bio") (Nasdaq: ETNB), a clinical-stage biopharmaceutical company focused on the development and commercialization...
► Artikel lesen
89BIO Aktie jetzt für 0€ handeln
06.06.89bio, Inc.: 89bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)336SAN FRANCISCO, June 06, 2025 (GLOBE NEWSWIRE) -- 89bio, Inc. (the "Company" or "89bio") (Nasdaq: ETNB), a clinical-stage biopharmaceutical company focused on the development and commercialization...
► Artikel lesen
30.05.89bio hält Jahreshauptversammlung ab, Direktoren gewählt1
30.05.89bio, Inc. - 8-K, Current Report2
09.05.89bio, Inc.: 89bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)405SAN FRANCISCO, May 09, 2025 (GLOBE NEWSWIRE) -- 89bio, Inc. (the "Company" or "89bio") (Nasdaq: ETNB), a clinical-stage biopharmaceutical company focused on the development and commercialization of...
► Artikel lesen
02.05.89bio, Inc. - 10-Q, Quarterly Report1
02.05.Cantor Fitzgerald cuts 89bio stock target to $55; keeps overweight3
01.05.89bio, Inc. - 8-K, Current Report1
09.04.89bio, Inc. - 8-K, Current Report2
14.03.Goldman Sachs starts 89bio stock with neutral, $11 target11
06.02.89bio, Inc.: 89bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)490SAN FRANCISCO, Feb. 06, 2025 (GLOBE NEWSWIRE) -- 89bio, Inc. (the "Company" or "89bio") (Nasdaq: ETNB), a clinical-stage biopharmaceutical company focused on the development and commercialization...
► Artikel lesen
19.12.2489bio, Inc.: 89bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)170SAN FRANCISCO, Dec. 19, 2024 (GLOBE NEWSWIRE) -- 89bio, Inc. (the "Company" or "89bio") (Nasdaq: ETNB), a clinical-stage biopharmaceutical company focused on the development and commercialization...
► Artikel lesen
29.11.2489bio, Inc.: 89bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)196SAN FRANCISCO, Nov. 29, 2024 (GLOBE NEWSWIRE) -- 89bio, Inc. (the "Company" or "89bio") (Nasdaq: ETNB), a clinical-stage biopharmaceutical company focused on the development and commercialization...
► Artikel lesen
15.11.2489bio, Inc.: 89bio Presents New Analyses Evaluating Pegozafermin and Potential Benefit of Non-Invasive Tests from the ENLIVEN Phase 2b Trial in MASH Patients at AASLD The Liver Meeting 2024247SAN FRANCISCO, Nov. 15, 2024 (GLOBE NEWSWIRE) -- 89bio, Inc. (Nasdaq: ETNB), a clinical-stage biopharmaceutical company focused on the development and commercialization of innovative therapies for...
► Artikel lesen
11.10.2489bio, Inc.: 89bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)320SAN FRANCISCO, Oct. 11, 2024 (GLOBE NEWSWIRE) -- 89bio, Inc. (the "Company" or "89bio") (Nasdaq: ETNB), a clinical-stage biopharmaceutical company focused on the development and commercialization...
► Artikel lesen
19.09.2489bio, Inc.: 89bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)174SAN FRANCISCO, Sept. 19, 2024 (GLOBE NEWSWIRE) -- 89bio, Inc. (the "Company" or "89bio") (Nasdaq: ETNB), a clinical-stage biopharmaceutical company focused on the development and commercialization...
► Artikel lesen
16.09.2489bio, Inc.: 89bio Announces Appointment of Teresa Perney, Ph.D. as Chief Regulatory and Quality Officer531SAN FRANCISCO, Sept. 16, 2024 (GLOBE NEWSWIRE) -- 89bio, Inc. (Nasdaq: ETNB), a clinical-stage biopharmaceutical company focused on the development and commercialization of innovative therapies for...
► Artikel lesen
20 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1